The long range goals are to develop O2 delivery pharmaceuticals based on extracellular recombinant hemoglobins (rHb). These next generation rHbs will be designed for optimal O2 transport, minimal interference with vasoregulation, enhanced resistance to denaturation, and increased expression levels in E. coli. Seven required properties are: (a) moderate O2 affinity (P50 5-30 mm Hg); (b) discrimination against CO binding; (c) large rate constants for oxygen binding and release; (d) significantly reduced rates of NO scavenging; (e) resistance to autooxidation and reactions with H2O2 (f) low rates of hemin dissociation; and (g) highly stable apoglobin structures. The mechanisms underlying these properties are being determined using sperm whale myoglobin as a simple prototype for the alpha and beta subunits of human hemoglobin, and the results are being used to develop strategies for solving specific problems in the clinical use and commercial development of extracellular hemoglobins (i.e., the hypertensive side effect and production costs). These mutagenesis studies will provide a database for evaluating more general principles for heme protein engineering. We will also address fundamental physiological questions about O2 transport and NO signaling and examine basic mechanisms of NO scavenging and O2 binding which apply to other key heme proteins, including flavohemoglobin NO dioxygenases.
The specific aims for the next five years are to: (1) design new rHb products with low rates of NO scavenging and more efficient O2 transport properties to eliminate the hypertensive side effect of extracellular hemoglobin; (2) determine the relative importance of P50, oxygen dissociation rate constants, and cooperativity on O2 transport in capillaries in order to define the minimum requirements for efficacy; (3) examine systematically all physiologically relevant reactions of NO with the iron atom in hemoglobin to avoid other potential side effects; (4) improve the in vivo stability and in vitro shelf-life of recombinant hemoglobins by enhancing their resistance to autooxidation, reaction with H2O2, and heme loss; and (5) increase expression yields and lower cost of production in E. coli by enhancing the stability of apohemoglobin.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL047020-11
Application #
6537007
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Mondoro, Traci
Project Start
1991-08-01
Project End
2005-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
11
Fiscal Year
2002
Total Cost
$257,839
Indirect Cost
Name
Rice University
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
050299031
City
Houston
State
TX
Country
United States
Zip Code
77005
Samuel, Premila P; Smith, Lucian P; Phillips Jr, George N et al. (2015) Apoglobin Stability Is the Major Factor Governing both Cell-free and in Vivo Expression of Holomyoglobin. J Biol Chem 290:23479-95
Nienhaus, Karin; Olson, John S; Nienhaus, G Ulrich (2013) An engineered heme-copper center in myoglobin: CO migration and binding. Biochim Biophys Acta 1834:1824-31
Boechi, Leonardo; Arrar, Mehrnoosh; Marti, Marcelo A et al. (2013) Hydrophobic effect drives oxygen uptake in myoglobin via histidine E7. J Biol Chem 288:6754-62
Varnado, Cornelius L; Mollan, Todd L; Birukou, Ivan et al. (2013) Development of recombinant hemoglobin-based oxygen carriers. Antioxid Redox Signal 18:2314-28
Schotte, Friedrich; Cho, Hyun Sun; Soman, Jayashree et al. (2013) Real-time tracking of CO migration and binding in the ? and ? subunits of human hemoglobin via 150-ps time-resolved Laue crystallography. Chem Phys 422:98-106
Mollan, Todd L; Banerjee, Sambuddha; Wu, Gang et al. (2013) ?-Hemoglobin stabilizing protein (AHSP) markedly decreases the redox potential and reactivity of ?-subunits of human HbA with hydrogen peroxide. J Biol Chem 288:4288-98
Dickson, Claire F; Rich, Anne M; D'Avigdor, William M H et al. (2013) ?-Hemoglobin-stabilizing protein (AHSP) perturbs the proximal heme pocket of oxy-?-hemoglobin and weakens the iron-oxygen bond. J Biol Chem 288:19986-20001
Mollan, Todd L; Abraham, Bindu; Strader, Michael Brad et al. (2012) Familial secondary erythrocytosis due to increased oxygen affinity is caused by destabilization of the T state of hemoglobin Brigham (ýýýýýýýýýý(Pro100Leu)). Protein Sci 21:1444-55
Tsai, Ah-Lim; Martin, Emil; Berka, Vladimir et al. (2012) How do heme-protein sensors exclude oxygen? Lessons learned from cytochrome c', Nostoc puntiforme heme nitric oxide/oxygen-binding domain, and soluble guanylyl cyclase. Antioxid Redox Signal 17:1246-63
Salter, Mallory D; Blouin, George C; Soman, Jayashree et al. (2012) Determination of ligand pathways in globins: apolar tunnels versus polar gates. J Biol Chem 287:33163-78

Showing the most recent 10 out of 108 publications